Unitree Robotics' STAR Market IPO Deep Dive: China's First Humanoid Robot Stock Goes Before Listing Committee
One: A Historic Day for China’s Humanoid Robot Industry
On June 1, 2026, Hangzhou Unitree Robotics Co., Ltd. faced the 31st listing review meeting of the Shanghai Stock Exchange’s Listing Review Committee. If approved, Unitree becomes the first “embodied AI stock” on the A-share market — and one of the very few profitable general-purpose robot companies going public anywhere in the world.
That same day, Unitree dominated global financial headlines for another reason. At Computex 2026 in Taipei, NVIDIA CEO Jensen Huang personally announced the “NVIDIA Isaac Root” — the chipmaker’s first commercially available research-grade humanoid robot platform — built on Unitree’s H2 humanoid robot.
Unitree’s journey from application submission on March 20 to the listing hearing on June 1 took just 66 days. That’s well below the typical STAR Market review cycle (often exceeding six months), widely seen as a signal of regulatory support for strategic “hard-tech” benchmark companies.
Two: Company Profile — From Four Legs to Two
Founded in 2016 by Wang Xingxing, a robotics engineer from Zhejiang University, Unitree’s vision has always been to make legged robots as ubiquitous as DJI made drones. The strategy: cost leadership through vertical integration.
Quadruped Roots
Unitree launched its first quadruped robot in 2017, followed by the Laikago, Aliengo, Go1, Go2, and B2 series. The Go2, launched in 2023 at just $1,600, slashed the entry price of quadruped robots from tens of thousands of dollars to consumer territory — triggering an explosion in the global quadruped market.
By 2025, Unitree commanded an estimated 60-70% of the global quadruped robot market, shipping over 10,000 units annually — far ahead of Boston Dynamics (Hyundai-owned) and any other competitor.
Entering Bipedal Territory
In 2023, Unitree unveiled its first general-purpose humanoid robot, the H1. In 2024 came the G1, a compact full-size humanoid priced at $16,000 — setting a new price floor for the category.
2025 marked a strategic inflection point. According to the IPO prospectus, humanoid robot revenue reached 51.53% of total revenue in the first three quarters of 2025, surpassing quadruped robots (42.3%) for the first time. The company shipped over 5,500 humanoid robots in the full year — more than Tesla’s Optimus and any other competitor globally.
Full-stack In-house Development
Unitree’s core competitive advantage lies in vertical integration. More than 90% of core components are self-developed and self-manufactured — covering motion control, servo drives, reducers, and embodied AI models. This approach drastically lowers production costs and gives the company strong pricing power.
The company holds over 200 core patents and boasts the highest technical maturity in the industry for mass-produced humanoid robots.
Three: IPO Details — 66-Day Sprint, RMB 4.2B Raise, All-Star Investor Roster
Timeline
| Date | Event |
|---|---|
| March 20, 2026 | IPO application formally accepted by SSE |
| April 2026 | On-site inspection completed, financial/compliance approved |
| May 25, 2026 | Prospectus published; hearing date set for June 1 |
| June 1, 2026 | Listing review meeting — 66 days total |
Issue Parameters
- New shares: No fewer than 40.4464 million
- Funds raised: RMB 4.202 billion ($620 million)
- Voting structure: Dual-class share structure (AB shares); founder Wang Xingxing retains majority voting power
- Sponsor: CITIC Securities
- Market: SSE STAR Market (科创板)
Use of Proceeds
| Project | Amount (RMB) | Share |
|---|---|---|
| Intelligent robot AI model R&D | 1.52 billion | 36.2% |
| Robot body R&D | 1.08 billion | 25.7% |
| New robot product development | 750 million | 17.8% |
| Smart robot manufacturing base | 852 million | 20.3% |
R&D-related spending accounts for over 85% of proceeds, squarely focused on frontier technology and capacity expansion.
Valuation Debate
Unitree’s last private round (C+, June 2025) valued the company at RMB 12.7 billion post-money (~$1.7 billion), with ByteDance and Sequoia China among the investors.
The IPO target valuation falls in the RMB 40-60 billion range ($5.5-8.3 billion). Market estimates for the post-listing market cap diverge significantly: conservative takes apply a 20x P/E (A-share tech average) for roughly RMB 50 billion; optimistic takes benchmark against STAR Market leaders like Cambricon or SMIC (50-80x P/E), implying RMB 80-100 billion.
Shareholder Roster
Founder Wang Xingxing holds 23.82% direct ownership and 68.78% voting rights through the dual-class structure. Meituan holds 9.65% as the second-largest shareholder. Tencent, Sequoia China, Matrix Partners, Shenzhen Capital, Alibaba, China Mobile, and Ant Group are among 30+ blue-chip institutional investors.
Notably, Meituan and Tencent are both financial investors and potential anchor customers — creating a “invest and buy” synergy rarely seen in hardware startups.
Four: Financial Deep Dive — The Profitability Myth Under a Microscope
“The only humanoid robot company in the world to achieve profitable scale” — Unitree’s proudest IPO pitch.
Revenue Explosion
| Year | Revenue (RMB) | YoY Growth | Adj. Net Profit (RMB) | Core Gross Margin |
|---|---|---|---|---|
| 2023 | 159 million | — | -18 million | 44.22% |
| 2024 | 392 million | 146.5% | 78 million | 56.74% |
| 2025 | 1.699 billion | 332.6% | 591 million | 60.13% |
The three-year revenue CAGR was an extraordinary 226.78%. 2025 adjusted net profit surged 652.78% year-over-year, far outpacing revenue growth. The gross margin expansion from 44.22% to 60.13% was driven by over 90% in-house component production — a level of vertical integration rare in global manufacturing.
Q1 2026: Growth Deceleration, Margin Pressure
Q1 2026 data signaled a “gear shift” phase:
- Revenue: RMB 423 million, up 68.49% — sharply down from 332% in 2025
- Adjusted net profit: RMB 40.25 million, down 52.55% year-over-year
The profit decline was driven by a significant ramp in R&D spending (AI models, algorithms) and selling expenses (global channel expansion). The company guided H1 2026 revenue of RMB 1.052-1.128 billion (+35.6-45.4% YoY) and adjusted net profit of RMB 236-283 million (-6.4% to -22.0% YoY) — a narrowing decline versus Q1, suggesting the margin trough may be near.
Revenue Mix Shift
In the first three quarters of 2025, humanoid robots contributed 51.53% of revenue, surpassing quadruped robots (42.3%) for the first time. Unitree has completed its identity transformation from “quadruped company” to “general-purpose robot company.”
International Revenue
More than 40% of revenue now comes from outside China, according to the IPO prospectus — spanning research institutions, industrial clients, and consumers across major global economies.
Five: Product Matrix — From $1,600 Robot Dogs to $90,000 Industrial Humanoids
Unitree’s product lineup spans the full price spectrum from consumer to industrial.
Quadruped Series
| Product | Segment | Starting Price | Key Specs |
|---|---|---|---|
| Go2 | Consumer/Developer | $1,600 | 3.5m/s speed, 4D LiDAR L2, 12 joints |
| B2 | Industrial | — | Power inspection, emergency rescue |
The Go2’s $1,600 price tag made quadruped robots a consumer product — the core weapon behind Unitree’s global market share dominance.
Humanoid Series
| Product | Segment | Price | Key Info |
|---|---|---|---|
| H1 | Full-size general | — | ~180cm, industrial focus, launched 2023 |
| H2 | Next-gen full-size | — | NVIDIA Isaac Root hardware platform |
| H2 Plus | Enhanced version | — | Shipping Oct 2026, global research |
| G1 | Compact full-size | $29,900 | CES 2026 debut, R&D/light industrial |
| Industrial humanoid | Manufacturing | Up to $90,000 | Deployed at BYD, Geely factories |
On June 1, NVIDIA announced the “NVIDIA Isaac Root” open humanoid robot platform powered by Unitree’s H2, with NVIDIA’s Jetson Thor (Blackwell GPU), GR00T AI models, and Singapore-based Sharpa dexterous hands. First customers include Stanford Robotics Center, ETH Zurich, UC San Diego’s ARCL Lab, and Seattle’s Ai2.
Six: Competitive Landscape — The Warring States of Humanoid Robotics
Global Humanoid Robot Players
| Company | HQ | Product | Funding/Val. | Status |
|---|---|---|---|---|
| Unitree | Hangzhou | H1/H2/G1/Go2 | C+, $1.7B val. | IPO underway |
| UBTECH | Shenzhen | Walker S/S2 | Listed (9880.HK) | Loss-making |
| Fourier | Shanghai | GR-1/2/3 | Series E, ~$1.1B | Pre-IPO |
| AgiBot | Beijing | — | — | Backdoor listing |
| Galbot | Beijing | — | $350M round | Unicorn |
| Tesla | US | Optimus | $1T+ parent | Prototype |
| Figure AI | US | Figure 02 | $2.6B val. | Prototype/trial |
| Boston Dynamics | US | Atlas/Spot | Hyundai-owned | High-end industrial |
Key Competitors
UBTECH Robotics (9880.HK) — Listed in Hong Kong in December 2023 as the world’s first publicly traded humanoid robot company. Its Walker S series saw 2,200% revenue growth in 2025, with total order value reaching RMB 1.1 billion. However, UBTECH remains unprofitable — creating a sharp contrast with Unitree (profitable and growing).
Fourier Intelligence — Started in rehabilitation robotics, pivoted to general-purpose humanoids. Cumulative funding near RMB 1 billion. Series E valuation ~RMB 8 billion. GR series has reached third generation. Differentiates through open-source hardware (N1, MIT license).
AgiBot — Founded by former Huawei “prodigy” Peng Zhihui. Pursuing backdoor listing via acquisition of a controlling stake in a listed company. Highly regarded technically, but commercialization lags Unitree significantly.
Tesla Optimus — Elon Musk positions Optimus as “bigger than the car business,” but mass production has been repeatedly delayed. As of 2026, Optimus remains largely in prototype testing — Unitree has already shipped more units.
Figure AI — Backed by OpenAI, Microsoft, and Amazon. ~$2.6 billion valuation, but still in prototype/pre-production with no commercial scale.
Unitree’s Competitive Moats
- Profitability uniqueness — Only profitable humanoid robot company globally (RMB 591M adj. profit in 2025)
- Volume leadership — 5,500+ humanoid units shipped in 2025, world #1
- Cost advantage — >90% in-house component production, strong pricing power
- Full-spectrum lineup — Consumer (Go2, G1) to industrial (H1/H2) coverage
Seven: Risks and Challenges — Under the High Valuation Hood
Growth Deceleration
Q1 2026 revenue growth plummeted from 332% to 68% year-over-year, with adjusted net profit cut in half. While the H1 2026 guidance suggests margin pressure is easing, the hypergrowth phase is clearly over. The question: is this a normal gear-shift after a scaling sprint, or an early warning of intensifying competition?
Valuation Gap
From a RMB 12.7 billion private valuation to an IPO target of RMB 40-60 billion (and beyond), Unitree is asking for a 3-4x step-up. At 20x 2025 peak earnings, the stock would trade around RMB 120 billion, not 500 billion. The premium relies on a “humanoid robots will be a $100 billion market” thesis — a timeline fraught with uncertainty.
Competitive Crowding
The humanoid robot space is getting crowded. Once Tesla Optimus enters mass production, it will directly challenge Unitree’s position. Chinese rivals (AgiBot, Galbot, Stardust) are accelerating funding rounds and production. NVIDIA’s platform partnership, while validating Unitree’s tech, also carries a “platform tax” risk — once standards are set, hardware margins may compress.
Geopolitical Exposure
Over 40% international revenue exposes Unitree to geopolitical headwinds. The NVIDIA partnership, while a strong validation, also places Unitree squarely in the crosshairs of US-China tech rivalry. Overseas market access restrictions could severely impact growth.
No “Killer App” Yet
Current humanoid robot deployment is largely limited to industrial manufacturing, warehouse logistics, and research institutions — all meaningful but not transformative markets. The real explosion awaits a “killer app” in consumer space (home service, elderly care, commercial service). Those applications remain technically and regulatory challenging.
Eight: Industry Significance — China’s “Cambrian Explosion” in Embodied AI
Unitree’s IPO is far more than a single company milestone. It marks China’s embodied AI industry transitioning from “technology validation” to “capitalization acceleration.”
Regulatory Signal
The STAR Market, established in 2019, has been the primary venue for hard-tech listing. Unitree’s 66-day approval speed, combined with multiple concurrent robotics IPO filings, signals clear regulatory support for the robotics sector.
Industry Resonance
Multiple Chinese humanoid robot companies are simultaneously accelerating capitalization:
- UBTECH already listed in Hong Kong
- Fourier Intelligence and Galbot actively preparing IPOs
- AgiBot pursuing backdoor listing
- Leju Robotics and DEEP Robotics applications accepted for ChiNext and STAR Market
2026 is widely recognized as the “Year Zero” of Chinese humanoid robot capitalization. TrendForce estimates that China’s humanoid robot market output grew 94% year-over-year in 2026.
A Global Benchmark
From a global perspective, Unitree is the only general-purpose robot company that: ① ships both quadruped and humanoid robots at scale; ② achieves sustained profitability; and ③ covers consumer, research, and industrial segments. NVIDIA’s choice of Unitree for its first humanoid platform is external validation of this unique position.
From Hardware Seller to Platform Definer
The NVIDIA partnership marks Unitree’s evolution from hardware manufacturer to “platform-level” company. NVIDIA Isaac Root is essentially an integrated development platform combining software stack, hardware, and simulation — with Unitree providing the most critical humanoid body. If this platform gains traction in research and education, Unitree will help define the robotics development standard for years to come.
The Road Ahead
The global humanoid robot market is projected to surpass $100 billion by 2030, according to TrendForce. Unitree, with its technology moat, cost leadership, and first-mover scale, is positioned to capture a significant share.
For the near term (H2 2026), the key watchpoints are: the final IPO pricing and oversubscription ratio, real-world deployment data at BYD and Geely factories, and the trajectory of margin recovery.
For the long term, if Unitree completes the transition from “product company” to “platform company” — selling not just robots but full-stack “robot + model + data” solutions — its value creation potential could far exceed today’s valuation scenarios.
June 1, 2026, marks not just Unitree’s listing hearing — it’s the day the humanoid robot industry formally entered its “capital-driven growth” phase.
Sources: Unitree IPO Prospectus (review draft), Shanghai Stock Exchange filings, CNBC, Global Times, 36Kr, Securities Times, Wall Street CN, MetaEra